Glasgow Prognostic Score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer

BACKGROUND: Interstitial lung disease (ILD) in patients with non‐small cell lung cancer (NSCLC) worsens the prognosis for overall survival (OS) due to chemotherapy‐triggered acute exacerbation (AE)‐ILD. The Glasgow Prognostic Score (GPS), which is based on serum C‐reactive protein and albumin levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Ryota, Takoi, Hiroyuki, Tsuji, Takao, Nagatomo, Yoko, Tanaka, Akane, Kinoshita, Hayato, Ono, Mariko, Ishiwari, Mayuko, Toriyama, Kazutoshi, Kono, Yuta, Togashi, Yuki, Yamaguchi, Kazuhiro, Yoshimura, Akinobu, Abe, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919129/
https://www.ncbi.nlm.nih.gov/pubmed/33480111
http://dx.doi.org/10.1111/1759-7714.13792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919129/
https://www.ncbi.nlm.nih.gov/pubmed/33480111
http://dx.doi.org/10.1111/1759-7714.13792

Ejemplares similares